國家衛生研究院 NHRI:Item 3990099045/11053
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 855395      Online Users : 1075
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/11053


    Title: The role of aberrant mitochondrial phosphoenolpyruvate carboxykinase expression in pancreatic neuroendocrine tumors
    Authors: Tsai, HJ;Chu, PY;Jiang, SS;Shan, YS;Hung, WC;Chen, MH;Lin, HY;Chen, YL;Chen, LT
    Contributors: National Institute of Cancer Research
    Abstract: Pancreatic neuroendocrine tumor (pNET) is a rare type of pancreatic cancer. Agents targeting angiogenesis and mTOR, sunitinib and everolimus, have been shown to prolong the progression free survival by around 11 months for pNET patients. To further improve the survival of pNET, a novel treatment is needed. Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M), which is encoded by PCK2, was demonstrated to play a critical role in the survival program initiated upon stress in cancer metabolism. Although elevated expression of PCK2 has been found in various tumors, the role of PEPCK-M aberration in cancers is not well understood. In our study, 12 of 21 pNET patients had high expression of PEPCK-M in the tumors. Knockdown of PCK2 inhibited the proliferation of pNET cells and enhanced the sensitivity of pNET cells to mTOR inhibitors. Knockdown of PCK2 promoted glycolysis but reduced mitochondrial oxidative phosphorylation of pNET cells. Combination of mTOR inhibitors and anti-glycolysis agent synergistically inhibited the proliferation of pNET cells. Therefore targeting PEPCK-M or glycolysis combined with mTOR inhibitors is a potential therapeutic approach for the treatment of pNET.
    Date: 2018-01
    Relation: Cancer Science. 2018 Jan;109(Suppl. 1):466.
    Link to: http://dx.doi.org/10.1111/cas.13499
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1347-9032&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000422694003154
    Appears in Collections:[Hui-Jen Tsai] Conference Papers/Meeting Abstract
    [Li-Tzong Chen] Conference Papers/Meeting Abstract
    [Wen-Chun Hung] Conference Papers/Meeting Abstract
    [Shih-Sheng Jiang] Conference Papers/Meeting Abstract

    Files in This Item:

    File SizeFormat
    ISI000422694003154.pdf48KbAdobe PDF313View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback